# PS-SYNTHETIC-SEALED-CREDENTIAL-BROKER-AZURE-CLI-BINDING-001 evidence

Runtime-inert post-review record. The required independent exact-SHA review
passed with no findings. This tail changes only this evidence file and its
matching receipt; it does not alter the reviewed implementation candidate.

## Reviewed candidate

- Base and reviewed `origin/main`: `854412656858962c97d3da52b2bd34d907e32830`
- Reviewed candidate: `a889a3d41e04630955a47b348553c8d5ac13d9f5`
- Reviewer: `agent:/root/sealed_broker_reviewer`
- Reviewed at: `2026-08-29T18:41:48Z`
- Result: Pass; findings: none

The reviewer independently confirmed the exact remote candidate, disjoint
current-main state, and only these implementation paths:

- `qa/synthetic_member/sealed_credential_broker/__init__.py`
- `qa/synthetic_member/docs/ATTENDED_PROOF_RUNBOOK.md`
- `tests/synthetic_member_qa/test_sealed_credential_broker.py`

The candidate selects only the current top-level App Service `enabled` and
`issuer` fields, strictly maps them within the worker to the prior closed
internal fields, preserves all metadata, tenant, authorization-origin, and
setting checks, and uses the confined CLI2 sibling Python runtime with
`-I -B -m azure.cli` for Graph-token acquisition. Its malformed authority,
runtime, and launcher failures remain fail-closed before Graph mutation.

## Validation and boundaries

Writer and reviewer validation passed:

- focused sealed-broker tests: 22/22;
- complete synthetic-member suite: 99/99;
- package registry, governance pointers, and delivery-preflight suite: 149/149;
- auth release-template tests: 7/7;
- guarded write preflight, Python compilation, and complete diff checks.

The evidence is fake-only and read-only. No Azure, Graph, browser, SQL,
identity, Workshop, deployment, schema, configuration, role, licensing,
billing, production mutation, or deletion operation occurred. A repository
merge does not authorize a live broker operation.

This post-review tail is limited to the receipt and this fixed evidence file.
It still requires normal PR policy/CI acceptance and merge; the claim remains
active until the separately governed close transition is accepted.
